{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:29:50Z","timestamp":1772166590753,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Congenital muscular dystrophies (CMD) are a clinically and genetically heterogeneous group of neuromuscular disorders characterized by muscle weakness. The two most prevalent forms of CMD, collagen VI-related myopathies (COL6RM) and laminin \u03b12 deficient CMD type 1A (MDC1A), are both caused by deficiency or dysfunction of extracellular matrix proteins. Previously, we showed that an intramuscular transplantation of human adipose-derived stem cells (ADSC) into the muscle of the\n                      <jats:italic>Col6a1<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>\u2212\/\u2212<\/jats:italic>\n                      <\/jats:sup>\n                      mice results in efficient stem cell engraftment, migration, long-term survival, and continuous production of the collagen VI protein, suggesting the feasibility of the systemic cellular therapy for COL6RM. In order for this therapeutic approach to work however, stem cells must be efficiently targeted to the entire body musculature. Thus, the main goal of this study is to test whether muscle homing of systemically transplanted ADSC can be enhanced by employing muscle-specific chemotactic signals originating from CMD-affected muscle tissue.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Proteomic screens of chemotactic molecules were conducted in the skeletal muscles of COL6RM- and MDC1A-affected patients and CMD mouse models to define the inflammatory and immune activities, thus, providing potential markers of disease activity or treatment effect. Also using a pre-clinical animal model, recapitulating mild Ullrich congenital muscular dystrophy (UCMD), the therapeutic relevance of identified chemotactic pathways was investigated in vivo\n                      <jats:italic>,<\/jats:italic>\n                      providing a basis for future clinical investigations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Comprehensive proteomic screens evaluating relevant human and mouse skeletal muscle biopsies offered chemotactic axes to enhance directional migration of systemically transplanted cells into CMD-affected muscles, including CCL5-CCR1\/3\/5, CCL2-CCR2, CXCL1\/2-CXCR1,2, and CXCL7-CXCR2. Also, the specific populations of ADSC selected with an affinity for the chemokines being released by damaged muscle showed efficient migration to injured site and presented their therapeutic effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, identified molecules provided insight into the mechanisms governing directional migration and intramuscular trafficking of systemically infused stem cells, thus, permitting broad and effective application of the therapeutic adult stem cells for CMD treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-01979-y","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T13:02:52Z","timestamp":1604322172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Congenital muscular dystrophy-associated inflammatory chemokines provide axes for effective recruitment of therapeutic adult stem cell into muscles"],"prefix":"10.1186","volume":"11","author":[{"given":"Vitali","family":"Alexeev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelyn","family":"Olavarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Bonaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9813-7184","authenticated-orcid":false,"given":"Olga","family":"Igoucheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"issue":"7","key":"1979_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneurol.2011.81","volume":"7","author":"CG Bonnemann","year":"2011","unstructured":"Bonnemann CG. The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol. 2011;7(7):379\u201390.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"1979_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.nurt.2008.08.004","volume":"5","author":"L Merlini","year":"2008","unstructured":"Merlini L, Bernardi P. Therapy of collagen VI-related myopathies (Bethlem and Ullrich). Neurotherapeutics. 2008;5(4):613\u20138.","journal-title":"Neurotherapeutics"},{"issue":"3","key":"1979_CR3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/jcp.21895","volume":"221","author":"A Farini","year":"2009","unstructured":"Farini A, Razini P, Erratico S, Torrente Y, Meregalli M. Cell based therapy for Duchenne muscular dystrophy. J Cell Physiol. 2009;221(3):526\u201334.","journal-title":"J Cell Physiol"},{"issue":"4","key":"1979_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2165\/11534300-000000000-00000","volume":"24","author":"M Meregalli","year":"2010","unstructured":"Meregalli M, Farini A, Parolini D, Maciotta S, Torrente Y. Stem cell therapies to treat muscular dystrophy: progress to date. BioDrugs. 2010;24(4):237\u201347.","journal-title":"BioDrugs"},{"key":"1979_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.nmd.2009.11.007","volume":"20","author":"J Meng","year":"2010","unstructured":"Meng J, Adkin CF, Arechavala-Gomeza V, Boldrin L, Muntoni F, Morgan JE. The contribution of human synovial stem cells to skeletal muscle regeneration. Neuromuscul Disord. 2010;20:6\u201315.","journal-title":"Neuromuscul Disord"},{"key":"1979_CR6","doi-asserted-by":"crossref","unstructured":"Vilquin JT, Guerette B, Puymirat J, Yaffe D, Tome FM, Fardeau M, et al. Myobla_st transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy\/dy) mouse muscles. Gene Ther. 1999;6(5):792\u2013800.","DOI":"10.1038\/sj.gt.3300889"},{"issue":"6","key":"1979_CR7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1083\/jcb.200212064","volume":"160","author":"C De Bari","year":"2003","unstructured":"De Bari C, Dell'Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM, Luyten FP. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol. 2003;160(6):909\u201318.","journal-title":"J Cell Biol"},{"issue":"9","key":"1979_CR8","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1634\/stemcells.2008-0043","volume":"26","author":"NM Vieira","year":"2008","unstructured":"Vieira NM, Bueno CR Jr, Brandalise V, Moraes LV, Zucconi E, Secco M, et al. SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression. Stem Cells. 2008;26(9):2391\u20138.","journal-title":"Stem Cells"},{"issue":"2","key":"1979_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12015-011-9304-0","volume":"8","author":"CH Pinheiro","year":"2012","unstructured":"Pinheiro CH, de Queiroz JC, Guimaraes-Ferreira L, Vitzel KF, Nachbar RT, de Sousa LG, et al. Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle. Stem Cell Rev Rep. 2012;8(2):363\u201374.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"1979_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/scrt411","volume":"5","author":"V Alexeev","year":"2014","unstructured":"Alexeev V, Arita M, Donahue A, Bonaldo P, Chu ML, Igoucheva O. Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophy. Stem Cell Res Ther. 2014;5(1):21.","journal-title":"Stem Cell Res Ther"},{"key":"1979_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fimmu.2014.00148","volume":"5","author":"E Eggenhofer","year":"2014","unstructured":"Eggenhofer E, Luk F, Dahlke MH, Hoogduijn MJ. The life and fate of mesenchymal stem cells. Front Immunol. 2014;5:148.","journal-title":"Front Immunol"},{"issue":"8","key":"1979_CR12","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.yexcr.2008.12.022","volume":"315","author":"T Binger","year":"2009","unstructured":"Binger T, Stich S, Andreas K, Kaps C, Sezer O, Notter M, et al. Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp Cell Res. 2009;315(8):1468\u201379.","journal-title":"Exp Cell Res"},{"issue":"3","key":"1979_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.biocel.2008.07.011","volume":"41","author":"G Kalwitz","year":"2009","unstructured":"Kalwitz G, Endres M, Neumann K, Skriner K, Ringe J, Sezer O, et al. Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7. Int J Biochem Cell Biol. 2009;41(3):649\u201358.","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"1979_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00441-009-0768-z","volume":"336","author":"S Stich","year":"2009","unstructured":"Stich S, Haag M, Haupl T, Sezer O, Notter M, Kaps C, et al. Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12. Cell Tissue Res. 2009;336(2):225\u201336.","journal-title":"Cell Tissue Res"},{"issue":"2","key":"1979_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1165\/rcmb.2004-0347OC","volume":"33","author":"A Demoule","year":"2005","unstructured":"Demoule A, Divangahi M, Danialou G, Gvozdic D, Larkin G, Bao W, et al. Expression and regulation of CC class chemokines in the dystrophic (mdx) diaphragm. Am J Respir Cell Mol Biol. 2005;33(2):178\u201385.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"1979_CR16","doi-asserted-by":"publisher","first-page":"C1031","DOI":"10.1152\/ajpcell.00467.2003","volume":"286","author":"GL Warren","year":"2004","unstructured":"Warren GL, O'Farrell L, Summan M, Hulderman T, Mishra D, Luster MI, et al. Role of CC chemokines in skeletal muscle functional restoration after injury. Am J Physiol Cell Physiol. 2004;286(5):C1031\u20136.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"1979_CR17","doi-asserted-by":"publisher","first-page":"E453","DOI":"10.1152\/ajpendo.00553.2012","volume":"304","author":"NJ Pillon","year":"2013","unstructured":"Pillon NJ, Bilan PJ, Fink LN, Klip A. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab. 2013;304(5):E453\u201365.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"1979_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.nmd.2013.12.011","volume":"24","author":"CG Bonnemann","year":"2014","unstructured":"Bonnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, et al. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014;24(4):289\u2013311.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"1979_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1212\/01.wnl.0000319661.70648.9b","volume":"71","author":"JW Day","year":"2008","unstructured":"Day JW. Congenital muscular dystrophy in a new age. Neurology. 2008;71(5):308\u20139.","journal-title":"Neurology"},{"issue":"13","key":"1979_CR20","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1093\/hmg\/7.13.2135","volume":"7","author":"P Bonaldo","year":"1998","unstructured":"Bonaldo P, Braghetta P, Zanetti M, Piccolo S, Volpin D, Bressan GM. Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum Mol Genet. 1998;7(13):2135\u201340.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1979_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13287-016-0388-y","volume":"7","author":"V Alexeev","year":"2016","unstructured":"Alexeev V, Donahue A, Uitto J, Igoucheva O. Chemotaxis-driven disease-site targeting of therapeutic adult stem cells in dystrophic epidermolysis bullosa. Stem Cell Res Ther. 2016;7(1):124.","journal-title":"Stem Cell Res Ther"},{"key":"1979_CR22","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1038\/ncomms2964","volume":"4","author":"A Urciuolo","year":"2013","unstructured":"Urciuolo A, Quarta M, Morbidoni V, Gattazzo F, Molon S, Grumati P, et al. Collagen VI regulates satellite cell self-renewal and muscle regeneration. Nat Commun. 2013;4:1964.","journal-title":"Nat Commun"},{"key":"1979_CR23","doi-asserted-by":"publisher","first-page":"540370","DOI":"10.1155\/2013\/540370","volume":"2013","author":"B De Paepe","year":"2013","unstructured":"De Paepe B, De Bleecker JL. Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy. Mediat Inflamm. 2013;2013:540370.","journal-title":"Mediat Inflamm"},{"issue":"6","key":"1979_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interf Cytokine Res. 2009;29(6):313\u201326.","journal-title":"J Interf Cytokine Res"},{"issue":"10","key":"1979_CR25","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1084\/jem.186.10.1757","volume":"186","author":"T Kurihara","year":"1997","unstructured":"Kurihara T, Warr G, Loy J, Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med. 1997;186(10):1757\u201362.","journal-title":"J Exp Med"},{"issue":"13","key":"1979_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.2174\/138955751513150923094709","volume":"15","author":"A Khalid","year":"2015","unstructured":"Khalid A, Wolfram J, Mu C, Mai J, Yang Z, Wang F, et al. Recent advances in discovering the role of CCL5 in metastatic breast cancer. Mini Rev Med Chem. 2015;15(13):1063\u201372.","journal-title":"Mini Rev Med Chem"},{"issue":"12","key":"1979_CR27","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1517\/14728222.2013.837886","volume":"17","author":"RE Marques","year":"2013","unstructured":"Marques RE, Guabiraba R, Russo RC, Teixeira MM. Targeting CCL5 in inflammation. Expert Opin Ther Targets. 2013;17(12):1439\u201360.","journal-title":"Expert Opin Ther Targets"},{"issue":"Pt 1","key":"1979_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1113\/jphysiol.2002.031450","volume":"547","author":"HX Nguyen","year":"2003","unstructured":"Nguyen HX, Tidball JG. Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro. J Physiol. 2003;547(Pt 1):125\u201332.","journal-title":"J Physiol"},{"key":"1979_CR29","doi-asserted-by":"publisher","first-page":"965631","DOI":"10.1155\/2014\/965631","volume":"2014","author":"Y Kharraz","year":"2014","unstructured":"Kharraz Y, Guerra J, Pessina P, Serrano AL, Munoz-Canoves P. Understanding the process of fibrosis in Duchenne muscular dystrophy. Biomed Res Int. 2014;2014:965631.","journal-title":"Biomed Res Int"},{"issue":"10","key":"1979_CR30","doi-asserted-by":"publisher","first-page":"e77430","DOI":"10.1371\/journal.pone.0077430","volume":"8","author":"S Paco","year":"2013","unstructured":"Paco S, Kalko SG, Jou C, Rodriguez MA, Corbera J, Muntoni F, et al. Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets. PLoS One. 2013;8(10):e77430.","journal-title":"PLoS One"},{"key":"1979_CR31","first-page":"212","volume":"5","author":"Y D\u00f6ring","year":"2014","unstructured":"D\u00f6ring Y, Pawig L, Weber C, Noels H. The CXCL12\/CXCR4 chemokine ligand\/receptor axis in cardiovascular disease. Front Physiol. 2014;5:212.","journal-title":"Front Physiol"},{"issue":"8","key":"1979_CR32","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1242\/dev.022418","volume":"136","author":"E Raz","year":"2009","unstructured":"Raz E, Mahabaleshwar H. Chemokine signaling in embryonic cell migration: a fisheye view. Development. 2009;136(8):1223\u20139.","journal-title":"Development"},{"issue":"3","key":"1979_CR33","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MOH.0b013e3283523e78","volume":"19","author":"D Vestweber","year":"2012","unstructured":"Vestweber D. Novel insights into leukocyte extravasation. Curr Olin Hematol. 2012;19(3):212\u20137.","journal-title":"Curr Olin Hematol"},{"issue":"3","key":"1979_CR34","first-page":"675","volume":"441","author":"Q Li","year":"2013","unstructured":"Li Q, Zhand A, Tao C, Li X, Jin P. The role of SDF-1-CXCR4\/CXCR7 axis in biological behaviors of adipose tissue-derived mesenchymal stem cells in vitro. BBRC. 2013;441(3):675\u201380.","journal-title":"BBRC."},{"issue":"Pt 18","key":"1979_CR35","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1242\/jcs.066241","volume":"123","author":"CA Griffin","year":"2010","unstructured":"Griffin CA, Apponi LH, Long KK, Pavlath GK. Chemokine expression and control of muscle cell migration during myogenesis. J Cell Sci. 2010;123(Pt 18):3052\u201360.","journal-title":"J Cell Sci"},{"issue":"9","key":"1979_CR36","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.bbadis.2014.05.033","volume":"1842","author":"F Tagliavini","year":"2014","unstructured":"Tagliavini F, Pellegrini C, Sardone F, Squarzoni S, Paulsson M, Wagener R, et al. Defective collagen VI alpha6 chain expression in the skeletal muscle of patients with collagen VI-related myopathies. Biochim Biophys Acta. 2014;1842(9):1604\u201312.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1979_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/jmg.2004.023754","volume":"42","author":"AK Lampe","year":"2005","unstructured":"Lampe AK, Dunn DM, von Niederhausern AC, Hamil C, Aoyagi A, Laval SH, et al. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet. 2005;42(2):108\u201320.","journal-title":"J Med Genet"},{"issue":"3","key":"1979_CR38","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1073\/pnas.0610270104","volume":"104","author":"A Angelin","year":"2007","unstructured":"Angelin A, Tiepolo T, Sabatelli P, Grumati P, Bergamin N, Golfieri C, et al. Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci U S A. 2007;104(3):991\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1979_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2350-11-44","volume":"11","author":"M Bovolenta","year":"2010","unstructured":"Bovolenta M, Neri M, Martoni E, Urciuolo A, Sabatelli P, Fabris M, et al. Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies. BMC Med Genet. 2010;11:44.","journal-title":"BMC Med Genet"},{"key":"1979_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijcard.2016.04.047","volume":"215","author":"J Finsterer","year":"2016","unstructured":"Finsterer J, Stollberger C, Keller H, Gencik M. Familial accumulation of sudden cardiac deaths and the LMNA variant c.868G>A (p.Glu290Lys). Int J Cardiol. 2016;215:84\u20136.","journal-title":"Int J Cardiol"},{"issue":"11","key":"1979_CR41","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/archneur.63.11.1617","volume":"63","author":"AJ van der Kooi","year":"2006","unstructured":"van der Kooi AJ, de Voogt WG, Bertini E, Merlini L, Talim FB, Ben Yaou R, et al. Cardiac and pulmonary investigations in Bethlem myopathy. Arch Neurol. 2006;63(11):1617\u201321.","journal-title":"Arch Neurol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01979-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-01979-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01979-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T13:14:09Z","timestamp":1604322849000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01979-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1979"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01979-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-56827\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-56827\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed in accordance with institutional and national guidelines and the \u201cGuide for the Care and Use of Laboratory Animals\u201d promulgated by NIH and were approve by the animal experimentation ethics committee of Thomas Jefferson University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"463"}}